Enhabit, Inc. (NYSE:EHAB) Receives $13.31 Average PT from Analysts

Enhabit, Inc. (NYSE:EHAB) has earned an average rating of “Hold” from the nine research firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $13.5714.

A number of equities analysts recently commented on EHAB shares. Deutsche Bank Aktiengesellschaft raised Enhabit to a “buy” rating in a report on Tuesday, January 13th. TD Cowen reissued a “hold” rating and set a $13.80 price target (up from $12.00) on shares of Enhabit in a report on Friday. Jefferies Financial Group cut Enhabit from a “buy” rating to a “hold” rating and upped their price target for the stock from $12.50 to $13.80 in a research report on Monday, February 23rd. Truist Financial set a $13.80 price objective on Enhabit in a research note on Monday, February 23rd. Finally, UBS Group reiterated a “neutral” rating and set a $13.80 price objective (up from $12.00) on shares of Enhabit in a research note on Tuesday, February 24th.

Enhabit Stock Up 0.1%

Shares of EHAB stock opened at $13.62 on Wednesday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.76. Enhabit has a 12 month low of $6.47 and a 12 month high of $13.64. The stock has a market cap of $690.81 million, a P/E ratio of -151.33 and a beta of 1.55. The company has a 50 day simple moving average of $11.13 and a two-hundred day simple moving average of $9.38.

Enhabit (NYSE:EHAB) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, hitting the consensus estimate of $0.14. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. The business had revenue of $270.40 million for the quarter, compared to analysts’ expectations of $270.56 million. On average, research analysts expect that Enhabit will post 0.22 earnings per share for the current year.

Hedge Funds Weigh In On Enhabit

Hedge funds have recently modified their holdings of the company. Corient Private Wealth LLC increased its stake in shares of Enhabit by 48.9% in the fourth quarter. Corient Private Wealth LLC now owns 14,942 shares of the company’s stock worth $138,000 after purchasing an additional 4,908 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Enhabit by 11.1% during the 4th quarter. Empowered Funds LLC now owns 262,221 shares of the company’s stock valued at $2,418,000 after buying an additional 26,287 shares in the last quarter. Polymer Capital Management US LLC purchased a new position in shares of Enhabit during the 4th quarter valued at $169,000. Eversept Partners LP bought a new position in Enhabit in the 4th quarter worth $2,015,000. Finally, Abel Hall LLC purchased a new stake in Enhabit in the 4th quarter worth $143,000.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.